Literature DB >> 15034620

Synthesis and evaluation of analogues of 10H-indolo[3,2-b]quinoline as G-quadruplex stabilising ligands and potential inhibitors of the enzyme telomerase.

Berangere Guyen1, Christoph M Schultes, Pascale Hazel, John Mann, Stephen Neidle.   

Abstract

We report here the synthesis and evaluation for telomerase-inhibitory and quadruplex DNA binding properties of several rationally-designed quindoline analogues, substituted at the 2- and 7- positions. The ability of these compounds to interact with and stabilise an intramolecular G-quadruplex DNA against increases in temperature was evaluated by a fluorescence-based (FRET) melting assay. The resulting T(m) values were found to correlate with their potency for telomerase inhibition, as measured in an in vitro telomerase TRAP assay. The interactions of a number of compounds with a quadruplex DNA molecular structure were simulated by molecular modelling methods. It is concluded that this class of compound represents a new chemical type suitable for further development as telomerase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034620     DOI: 10.1039/b316055f

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  18 in total

1.  Solution structure of a 2:1 quindoline-c-MYC G-quadruplex: insights into G-quadruplex-interactive small molecule drug design.

Authors:  Jixun Dai; Megan Carver; Laurence H Hurley; Danzhou Yang
Journal:  J Am Chem Soc       Date:  2011-10-14       Impact factor: 15.419

2.  Targeting human telomerase for cancer therapeutics.

Authors:  Lionel Guittat; Patrizia Alberti; Dennis Gomez; Anne De Cian; Gaëlle Pennarun; Thibault Lemarteleur; Chafke Belmokhtar; Rajaa Paterski; Hamid Morjani; Chantal Trentesaux; Eliane Mandine; François Boussin; Patrick Mailliet; Laurent Lacroix; Jean-François Riou; Jean-Louis Mergny
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

3.  Exploiting σ-hole interaction to design small uncharged ligand molecules to stabilize G-quadruplex-DNA: a computational study.

Authors:  Mrinal Kanti Si; Anusuya Saha; Bishwajit Ganguly
Journal:  J Mol Model       Date:  2020-02-01       Impact factor: 1.810

4.  Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter.

Authors:  Peda V L Boddupally; Seongmin Hahn; Cristina Beman; Biswanath De; Tracy A Brooks; Vijay Gokhale; Laurence H Hurley
Journal:  J Med Chem       Date:  2012-06-25       Impact factor: 7.446

5.  Gaining insights into the small molecule targeting of the G-quadruplex in the c-MYC promoter using NMR and an allele-specific transcriptional assay.

Authors:  Christine E Kaiser; Vijay Gokhale; Danzhou Yang; Laurence H Hurley
Journal:  Top Curr Chem       Date:  2013

6.  Recognition and discrimination of DNA quadruplexes by acridine-peptide conjugates.

Authors:  James E Redman; J M Granadino-Roldán; James A Schouten; Sylvain Ladame; Anthony P Reszka; Stephen Neidle; Shankar Balasubramanian
Journal:  Org Biomol Chem       Date:  2008-10-30       Impact factor: 3.876

Review 7.  Indolo[3,2-b]quinolines: synthesis, biological evaluation and structure activity-relationships.

Authors:  Eyunni V K Suresh Kumar; Jagan R Etukala; Seth Y Ablordeppey
Journal:  Mini Rev Med Chem       Date:  2008-06       Impact factor: 3.862

8.  Discovery of new G-quadruplex binding chemotypes.

Authors:  Stephan A Ohnmacht; Ehsan Varavipour; Rupesh Nanjunda; Ingrida Pazitna; Gloria Di Vita; Mekala Gunaratnam; Arvind Kumar; Mohamed A Ismail; David W Boykin; W David Wilson; Stephen Neidle
Journal:  Chem Commun (Camb)       Date:  2014-01-28       Impact factor: 6.222

Review 9.  Sequence, stability, and structure of G-quadruplexes and their interactions with drugs.

Authors:  Yuwei Chen; Danzhou Yang
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2012-09

Review 10.  Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?

Authors:  Shankar Balasubramanian; Laurence H Hurley; Stephen Neidle
Journal:  Nat Rev Drug Discov       Date:  2011-04       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.